Will longer antimicrobial patents improve global public health?
نویسندگان
چکیده
منابع مشابه
Will longer antimicrobial patents improve global public health?
The problem of antimicrobial resistance has led some infectious disease experts and their professional societies to propose the use of transferable intellectual property rights (wildcard patents) and patent term extensions as methods to encourage antimicrobial research and development. We evaluate recent approvals of new antimicrobial classes and find that the number of new introductions is hig...
متن کاملGlobal health and university patents.
U niversities have long been important in the development of life-saving medicines and technologies, and they once considered patenting to be antithetical to academic science and public health. Now a fierce debate rages about whether and when patents promote innovation, but in practice, the patenting worm has turned: Seeking revenues and ways to commercialize their inventions, U.S. universities...
متن کاملStrengthening public health education and training to improve global health.
Public health training and education have existed for over a century,1 yet there is little systematic evidence on whether current approaches prepare graduates to improve health by developing, evaluating and implementing effective and equityoriented public health programmes. There are three reasons to document and debate this topic worldwide and disproportionately focus on lowand middle-income c...
متن کاملCRISPR, Patents, and the Public Health
Patent issues surrounding CRISPR, the revolutionary genetic editing technology, may have important implications for the public health. Patents maintain high prices for novel therapies, limiting patient access. Relatedly, insurance coverage for expensive therapies is waning. Patents also misallocate research and development resources to profitable disease indications rather than those that neces...
متن کاملDo patents work for public health?
Q: Why did the CIPIH fail to deliver its report on time in 2005? A: The CIPIH had to deal with a very difficult issue: how to promote the development of medicines for diseases prevailing in developing countries. These diseases are neglected in industry’s R&D (research and development) budgets because selling medicines to treat them is not profitable enough. The CIPIH chose to cover issues rangi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Infectious Diseases
سال: 2007
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(07)70188-3